| 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.276 | 10.654 | 11.999 | 11.343 | 6.511 |
| 總資產報酬率 ROA (%) | 0.837 | 7.000 | 8.212 | 8.020 | 5.132 |
| 投入資產回報率 ROIC (%) | 0.939 | 7.923 | 9.257 | 8.809 | 5.564 | 邊際利潤分析 |
| 銷售毛利率 (%) | 37.738 | 39.364 | 41.878 | 41.320 | 36.068 |
| 營業利潤率 (%) | 17.725 | 22.422 | 24.653 | 23.587 | 20.686 |
| 息稅前利潤/營業總收入 (%) | 19.569 | 23.969 | 26.353 | 24.601 | 20.338 |
| 淨利潤/營業總收入 (%) | 13.868 | 19.405 | 21.107 | 20.748 | 18.147 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 104.376 | 102.457 | 102.135 | 90.607 | 80.089 |
| 價值變動淨收益/利潤總額(%) | 3.855 | 1.994 | -2.917 | 3.028 | 13.605 |
| 營業外收支淨額/利潤總額(%) | -0.383 | -0.349 | 0.038 | -0.755 | -0.619 | 償債能力分析 |
| 流動比率 (X) | 2.362 | 2.369 | 3.613 | 4.149 | 4.932 |
| 速動比率 (X) | 0.832 | 1.129 | 1.737 | 1.619 | 2.296 |
| 資產負債率 (%) | 32.487 | 34.623 | 31.940 | 28.891 | 27.493 |
| 帶息債務/全部投入資本 (%) | 23.222 | 24.220 | 21.539 | 18.183 | 21.319 |
| 股東權益/帶息債務 (%) | 319.044 | 301.650 | 352.116 | 432.487 | 359.395 |
| 股東權益/負債合計 (%) | 205.085 | 186.297 | 209.970 | 242.351 | 259.953 |
| 利息保障倍數 (X) | 10.237 | 14.747 | 15.591 | 20.649 | -92.217 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 140.599 | 61.992 | 28.165 | 27.167 | 62.315 |
| 存貨周轉天數 (天) | 597.360 | 392.830 | 377.450 | 374.036 | 432.981 |
002880 衛光生物
按盤價 
22.310 +0.380 (+1.73%)
22.310 +0.380 (+1.73%)| 備註： | 報價延遲最少15分鐘，資料更新時間為 12/06/2026 16:30 |
